Center of Reproductive Medicine and Andrology, Clinical Andrology, University of Muenster, Albert-Schweitzer-Campus 1, Building D11, D-48149 Muenster, Germany.
Eur J Endocrinol. 2014 Mar 13;170(4):K11-7. doi: 10.1530/EJE-13-0449. Print 2014 Apr.
Classical congenital adrenal hyperplasia (CAH), a genetic disorder characterized by 21-hydroxylase deficiency, impairs male fertility, if insufficiently treated.
A 30-year-old male was referred to our clinic for endocrine and fertility assessment after undergoing unilateral orchiectomy for a suspected testicular tumor. Histopathological evaluation of the removed testis revealed atrophy and testicular adrenal rest tumors (TARTs) and raised the suspicion of underlying CAH. The remaining testis was also atrophic (5 ml) with minor TARTs. Serum 17-hydroxyprogesterone levels were elevated, cortisol levels were at the lower limit of normal range, and gonadotropins at prepubertal levels, but serum testosterone levels were within the normal adult range. Semen analysis revealed azoospermia. CAH was confirmed by a homozygous mutation g.655A/C>G (IVS2-13A/C>G) in CYP21A2. Hydrocortisone (24 mg/m(2)) administered to suppress ACTH and adrenal androgen overproduction unmasked deficient testicular testosterone production. As azoospermia persisted due to sustained hypogonadotropic hypogonadism, a combined s.c. gonadotropin replacement with human chorionic gonadotropin (hCG) (1500 IU twice weekly) and FSH (human menopausal gondadotropin (hMG) 150 IU three times weekly) was initiated.
Normalization of testosterone levels and a stable low sperm concentration (0.5 mill/ml) with good sperm motility (85% A+B progressive) were achieved within 21 months of treatment. Despite persisting TARTs, while receiving treatment, the patient successfully impregnated his wife twice, the latter impregnation leading to the birth of a healthy girl.
TARTs in unrecognized (simple virilizing) CAH may lead to unnecessary orchiectomy. In hypogonadotropic, azoospermic CAH, a combined treatment with oral corticosteroids and subcutaneously administered hCG and FSH can successfully restore testicular testosterone production and fertility, even if only one hypoplastic and atrophic testis with adrenal rest tumors is present.
经典型先天性肾上腺皮质增生症(CAH)是一种遗传疾病,其特征为 21-羟化酶缺乏,若治疗不充分则会损害男性生育能力。
一名 30 岁男性因疑似睾丸肿瘤而接受单侧睾丸切除术,随后被转至我们的内分泌和生育评估诊所。切除睾丸的组织病理学评估显示为萎缩和睾丸肾上腺残株肿瘤(TARTs),这引起了潜在 CAH 的怀疑。另一侧睾丸也出现萎缩(5ml)并伴有较小的 TARTs。血清 17-羟孕酮水平升高,皮质醇水平处于正常范围下限,促性腺激素处于青春期前水平,但血清睾酮水平处于正常成人范围。精液分析显示无精子症。CYP21A2 的纯合突变 g.655A/C>G(IVS2-13A/C>G)证实了 CAH 的诊断。给予氢化可的松(24mg/m2)以抑制 ACTH 和肾上腺雄激素的过度产生,从而揭示了睾丸睾酮产生不足。由于持续的促性腺激素低下性性腺功能减退症导致无精子症持续存在,因此开始联合皮下给予人绒毛膜促性腺激素(hCG)(1500IU,每周两次)和促卵泡激素(hMG)(人绝经促性腺激素(hMG)150IU,每周三次)进行促性腺激素替代治疗。
经过 21 个月的治疗,睾酮水平正常化,精子浓度稳定(0.5 毫/ml),精子活力良好(85% A+B 级)。尽管在接受治疗时仍存在 TARTs,但患者成功使妻子怀孕两次,后者怀孕导致一名健康女孩的出生。
在未被识别的(单纯性男性化)CAH 中,TARTs 可能导致不必要的睾丸切除术。在促性腺激素低下、无精子症的 CAH 中,联合口服皮质激素和皮下给予 hCG 和 FSH 治疗可以成功恢复睾丸睾酮产生和生育能力,即使只有一个存在肾上腺残株肿瘤的发育不良和萎缩的睾丸。